COMMUNIQUÉS West-GlobeNewswire
-
Damora Announces Redomestication from Delaware to Cayman Islands
17/07/2026 -
Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives
17/07/2026 -
Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026
17/07/2026 -
Sienna Announces Long-Term Care Redevelopment in Greater Toronto Area
17/07/2026 -
Arch Biopartners Engages Private Laboratory to Accelerate IL-32 Chronic Kidney Disease Program
17/07/2026 -
SS Innovations To Showcase the SSi Mantra Surgical Robotic System at SRS 2026
17/07/2026 -
SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology
17/07/2026 -
Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations
17/07/2026 -
Orion Group Half-Year Financial Report January–June 2026
17/07/2026 -
BrewDog and Tilray Brands Unlock £1 Million Bar Tab for Football Fans Across England, Scotland and Ireland
17/07/2026 -
Clearmind Medicine Commends Federal Momentum in Advancing Psychedelic-Based Therapies for Mental Health and Addiction
17/07/2026 -
Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026
17/07/2026 -
Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/07/2026 -
European Commission approves JASCAYD®, bringing well-tolerated, novel oral treatment for IPF and PPF to the EU
17/07/2026 -
Mission Therapeutics strikes deal worth up to $292 million for Dimerix Ltd to develop Acute Kidney Injury asset MTX652, sharpens focus on its CNS pipeline
17/07/2026 -
Orion Corporation’s financial reporting and Annual General Meeting in 2027
17/07/2026 -
Enjoin Reports 923% Average ROI Delivered in Q1 2026
17/07/2026 -
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
16/07/2026 -
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period
16/07/2026
Pages